chemotherapy agents in ovarian cancer
Published 9 years ago • 315 plays • Length 5:24Download video MP4
Download video MP3
Similar videos
-
1:23
dr. duska on neoadjuvant chemo vs upfront surgery in ovarian cancer
-
1:15
dr. salani on choosing among iv, ip, and dose-dense chemo regimens in ovarian cancer
-
2:27
dr. berger on chemotherapy delivery options in ovarian cancer
-
3:51
chemotherapy in early-stage ovarian cancer
-
6:13
chemotherapy regimens for ovarian cancer
-
1:19
dr. naumann on improving outcomes with chemotherapy in ovarian cancer
-
2:19
dr. hoffman on research regarding neoadjuvant chemo and primary debulking in ovarian cancer
-
23:15
is it time to change upfront chemotherapy for ovarian cancer?
-
1:41
dr. copeland on the role of chemotherapy in ovarian cancer
-
5:40
combination veliparib and chemotherapy in ovarian cancer
-
1:07
dr. scribner on the role of chemotherapy in ovarian cancer
-
8:15
ovarian cancer: neoadjuvant chemo vs primary debulking
-
6:20
parp inhibitors in recurrent ovarian cancer
-
1:56
dr. sanaz memarzadeh on chemotherapy resistant tumor cells in ovarian cancer
-
7:18
antiangiogenic agents in ovarian cancer
-
1:20
dr. naumann on neoadjuvant chemotherapy in patients with ovarian cancer
-
1:48
dr. penson on olaparib monotherapy vs chemo for ovarian cancer
-
10:41
fda approvals in ovarian cancer and for mec chemo, promising data in lung cancer, and more
-
1:14
dr. coleman on rationale for using veliparib and chemotherapy in ovarian cancer